LTUS (Lotus Pharma) make good of .28/share for 2008, and .35/share 2009
Today's news from LTUS increases fully diluted share total to 50M 9an increase of 5.75M shares.
I'm not a fan of dilution (who is?), but their make good targets on the placement include .28/share income for 2008 and .35/share income for 2009.
That's a PE of 3 and 2 for 2008 and 2009 respectively based on SP of .81/share. Stupid cheap- especially for a stock now committed to a Nasdaq listing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.